Trial Profile
The effectiveness and safety of neoadjuvant chemotherapy of Abraxane combined with cisplatin, concurrent chemotherapy of cisplatin and IMRT in local-regionally advanced nasopharyngeal carcinoma : a prospective, non-controlled clinical trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary)
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Therapeutic Use
- 29 Nov 2012 New trial record